Status:
COMPLETED
Integrated Management Enhances Functional Gains in Children With Cerebral Palsy Treated by BoNT-A
Lead Sponsor:
Kocaeli University
Conditions:
Cerebral Palsy
Eligibility:
All Genders
5-16 years
Phase:
PHASE3
Brief Summary
Evidence from literature support the use of Botulinum toxin A (BoNT-A) for upper limb spasticity management in children with cerebral palsy (CP). Constraint Induced Movement Therapy (CIMT) and Bilater...
Detailed Description
Although BoNT-A is effective in spasticity management there is inconclusive evidence to support its usage for improvement in upper limb activity and function. Combination of BoNT-A and occupational th...
Eligibility Criteria
Inclusion
- diagnosis of unilateral cerebral palsy
- able to activate wrist and finger extensors
- being scheduled for BoNT-A treatment for upper limb
Exclusion
- significant loss of wrist and or fingers
- history of orthopedic surgery to plegic upper limb
Key Trial Info
Start Date :
January 18 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03302871
Start Date
January 18 2016
End Date
January 30 2020
Last Update
April 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kocaeli University
Kocaeli, Turkey (Türkiye), 41050